1.Minkov GA, Halacheva KS, Yovtchev YP, Gulubova MV. Pathophysiological mechanisms of acute pancreatitis define inflammatory markers of clinical prognosis. Pancreas 2015;44:713–17.
2.Beger HG, Rau B, Isenmann R. Natural history of necrotizing pancreatitis. Pancreatology. 2003;3:93–101.
3.Tsui NC, Zhao E, Li Z, et al. Microbiological findings in secondary infection of severe acute pancreatitis: a retrospective clinical study. Pancreas. 2009;38:499–502.
4.Cacopardo B, Pinzone M, Berretta S, Fisichella R, Di Vita M, Zanghì G, Cappellani A, Nunnari G, Zanghì A.Localized and systemic bacterial infections in necrotizing pancreatitis submitted to surgical necrosectomy or percutaneous drainage of necrotic secretions.BMC Surg. 2013;13 Suppl 2:S50. doi: 10.1186/1471-2482-13-S2-S50. Epub 2013 Oct 8.
5.Schmid SW, Uhl W, Friess H, Malfertheiner P, Buchler MW. The role of infection in acute pancreatitis. Gut. 1999;13(2):311–316.
6.Renner IG, Savage WT, 3rd, Pantoja JL, Renner VJ. Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig Dis Sci. 1985 Oct;30(10):1005–1018.
7.Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y. Immunosuppression in patients with severe acute pancreatitis.J Gastroenterol. 2006 Aug;41(8):779-84.
8.Hans G Beger and Bettina M Rau.Severe acute pancreatitis: Clinical course and management.World J Gastroenterol. 2007 Oct 14; 13(38): 5043–5051.Published online 2007 Oct 14. doi: 10.3748/wjg.v13.i38.5043
9.Li JP, Yang J, Huang JR, Jiang DL, Zhang F, Liu MF, et al. Immunosuppression and the infection in patients with early SAP. Front Biosci (Landmark Ed) 2013;18:892–900. doi: 10.2741/4150.
10.Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677–704. doi: 10.1146/annurev. immunol. 26.021607. 090331.
11.Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, et al. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care. 2014;18(1):R3. doi: 10.1186/cc13176.
12.Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K, et al. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care. 2010;14(6):R220. doi:10.1186/cc9354.
13.Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2001;2(3):261–8. doi: 10.1038/85330.
14.Dai S, Jia R, Zhang X, Fang Q, Huang L. The PD-1/PD-Ls pathway and autoimmune diseases. Cell Immunol 290 1:72-79, 2014.
15.Frigola, X, Inman, BA, Lohse, CM et al. Identification of a soluble form of B7‐H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clin Cancer Res2011; 17: 1915-23.
16.Zhang Y, Li J, Lou J, Zhou Y, Bo L, Zhu J, Zhu K, Wan X, Cai Z, Deng X. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients. Crit Care. 2011;15:R70. doi: 10.1186/cc10059.
17.Tingting Pan,Tianyun Zhou,Lei Li,Zhaojun Liu,Ying Chen,Enqiang Mao,Meiling Li, Hongping Qu, JialinLiu.Monocyte programmed death ligand-1 expression is an early marker for predicting infectious complications in acute pancreatitis.Crit Care.2017; 21: 186. Published online 2017 Jul 14. doi: 10.1186/s13054-017-1781-3.
18.Zhao Y, Jia Y, Li C, Shao R, Fang Y.Predictive Value of Soluble Programmed Death-1 for Severe Sepsisand Septic Shock During the First Week in an Intensive Care Unit.Shock. 2019 Mar;51(3):289-297. doi: 10.1097/SHK.0000000000001171.
19.Zhao Y, Jia Y, Li C, Fang Y, Shao R.The risk stratification and prognostic evaluation of soluble programmed death-1 on patients with sepsis in emergency department.Am J Emerg Med.2018 Jan;36(1):43-48.doi: 10.1016/j.ajem.2017.07.002. Epub 2017 Jul 4.
20.Banks PA,Bollen TL,Dervenis C,et a1.Classification of acute panereatitis-2012:revision of the Atlanta classification and definitions by international consensus[J].Gut,2013,62(1):102-111.
21.Naskalski JW1, Kusnierz-Cabala B, Kedra B, Dumnicka P, Panek J,Maziarz B.Correlation of peripheral blood monocyte and neutrophil direct counts with plasma inflammatory cytokines and TNF-alpha soluble receptors in the initial phase of acute pancreatitis.Adv Med Sci.2007;52:129-34
22.Yu Pan, Haizong Fang, Fengchun Lu, Minggui Pan, Fei Chen, Ping Xiong, Yi Yao, Heguang Huang.Ulinastatin ameliorates tissue damage of severe acute pancreatitis through modulating regulatory T cells.J Inflamm (Lond) 2017; 14: 7. Published online 2017 Mar 20. doi: 10.1186/s12950-017-0154-7.
23.Wu H, Miao M, Zhang G, Hu Y, Ming Z, Zhang X. Soluble PD-1 is associated with aberrant regulation of T cells activation in aplastic anemia. Immunol Invest 38 5:408–421, 2009.
24.Greisen SR, Rasmussen TK, Stengaard-Pedersen K, Hetland ML, Hørslev-Petersen K, Hvid M, Deleuran B. Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis. Scand J Rheumatol 43 2:101–108, 2014.
25.Han XC, Zhang YC, Wang Y, Jia MK. Clinical evaluation of serum interleukin 10 in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int. 2003;2(1):135–138.
26.Zhao Y, Jia Y, Li C, Shao R, Fang Y. Predictive Value of Soluble Programmed Death-1 for Severe Sepsis and Septic Shock During the First Week in an Intensive Care Unit.Shock. 2019 Mar;51(3):289-297. doi: 10.1097/SHK.0000000000001171.
27.Takeyama Y,Takas K,Ueda T,Hori Y,Goshima M,Kuroda Y.Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death.J Gastrointest Surg. 2000 Jul-Aug;4(4):379-87.
28.Mentula P, Kylänpää-Bäck ML, Kemppainen E, Takala A, Jansson SE, Kautiainen H, Puolakkainen P, Haapiainen R, Repo H.Decreased HLA (human leucocyte antigen)-DR expression on peripheral blood monocytes predicts the development of organ failure in patients with acute pancreatitis.Clin Sci (Lond). 2003 Oct;105(4):409-17.
29. Hagjer S, Kumar N.Evaluation of the BISAP scoring system in prognostication of acute pancreatitis – A prospective observational study.Int J Surg. 2018 Jun;54(Pt A):76-81. doi: 10.1016/j.ijsu.2018.04.026. Epub 2018 Apr 21.
30.Vasudevan S, Goswami P, Sonika U, Thakur B, Sreenivas V, Saraya A.Comparison of Various Scoring Systems and Biochemical Markers in Predicting the Outcome in AcutePancreatitis.Pancreas.2018Jan;47(1):65-71.doi:10.1097/MPA.0000000000000957.
31.Mounzer R, Langmead CJ, Wu BU, Evans AC, Bishehsari F, Muddana V, Singh VK, Slivka A, Whitcomb DC, Yadav D, Banks PA, Papachristou GI.Comparison of Existing Clinical Scoring Systems to Predict Persistent Organ Failure in Patients With Acute Pancreatitis.Gastroenterology. 2012 Jun;142(7):1476-82; quiz e15-6. doi: 10.1053/j.gastro.2012.03.005. Epub 2012 Mar 13.
32.Papachristou GI,Muddana V,Yadav D,O'Connell M,Sanders MK, Slivka A,Whitcomb DC.Comparison of BISAP,Ranson's,APACHE-II,and CTSI Scores in Predicting Organ Failure, Complications, and Mortality in Acute Pancreatitis.Am J Gastroenterol. 2010 Feb;105(2):435-41; quiz 442. doi: 10.1038/ajg.2009.622. Epub 2009 Oct 27.
33.Anubhav Harshit Kumar, Mahavir Singh Griwan.A comparison of APACHE II, BISAP, Ranson’s score and modified CTSI in predicting the severity of acute pancreatitis based on the 2012 revised Atlanta Classification.Gastroenterol Rep (Oxf) 2018 May; 6(2): 127–131. Published online 2017 Jul 28. doi: 10.1093/gastro/gox029